XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Earnings Per Share ("EPS") | 6 Months Ended
--- | ---
Oct. 29, 2022
Earnings Per Share [Abstract] |
Earnings Per Share ("EPS") | Earnings Per Share ("EPS") The following is a reconciliation of the net (loss) income and common share amounts used in the calculation of basic and diluted EPS for the three and six months ended October 29, 2022 and October 30, 2021:
| Net (loss) income |  | Shares |  | Per share (loss) income
For the three months ended October 29, 2022 |  |  |  |  |
Basic and diluted (loss) earnings per share | $ | (12,984) |  |  | 45,317 |  |  | $ | (0.29) |
Diluted (loss) earnings per share | $ | (12,984) |  |  | 45,317 |  |  | $ | (0.29) |
For the three months ended October 30, 2021 |  |  |  |  |
Basic earnings per share | $ | 2,374 |  |  | 45,350 |  |  | $ | 0.05 |
Dilution associated with stock compensation plans | — |  |  | 149 |  |  | — |
Diluted earnings per share | $ | 2,374 |  |  | 45,499 |  |  | $ | 0.05 |
For the six months ended October 29, 2022 |  |  |  |  |
Basic and diluted (loss) earnings per share | $ | (18,310) |  |  | 45,258 |  |  | $ | (0.40) |
Diluted (loss) earnings per share | $ | (18,310) |  |  | 45,258 |  |  | $ | (0.40) |
For the six months ended October 30, 2021 |  |  |  |  |
Basic earnings per share | $ | 6,059 |  |  | 45,271 |  |  | $ | 0.13 |
Dilution associated with stock compensation plans | — |  |  | 219 |  |  | — |
Diluted earnings per share | $ | 6,059 |  |  | 45,490 |  |  | $ | 0.13 |
Options outstanding to purchase 2,063 shares of common stock with a weighted average exercise price of $7.51 for the three months ended October 29, 2022 and 1,943 shares of common stock with a weighted average exercise price of $9.22 for the three months ended October 30, 2021 were not included in the computation of diluted earnings per share because the effects would be anti-dilutive. Options outstanding to purchase 2,082 shares of common stock with a weighted average exercise price of $7.82 for the six months ended October 29, 2022 and 1,877 shares of common stock with a weighted average exercise price of $9.37 for the six months ended October 30, 2021 were not included in the computation of diluted earnings per share because the effects would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration